Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Olivier Louis Chinot"'
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
PFS6 and PFS12 depending of the in intention-to-treat or per protocole analyses as investigator or central review analyses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a84ffcc6c5b0c9c895299bbe94b0f11
https://doi.org/10.1158/1078-0432.22479977
https://doi.org/10.1158/1078-0432.22479977
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Table S1: Patient characteristics T : Tumor ; IK : Karnofski index; NA : Not available, SST2 : SST2 receptor expression (IRS Immunoreactivity score ) ; Conv: Convexity; RT: Radiotherapy; RS: Radiosurgery; CT chemotherapy * : for the NF2 genomic alter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f1a8b786104b2c79593528744cbd4e
https://doi.org/10.1158/1078-0432.22479983.v1
https://doi.org/10.1158/1078-0432.22479983.v1
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Study of correlation between SSTR2A receptor expression and growth rate (GR) before and under treatment as with progression. No significant correlation was observed. Immunohistochemical detection of SSTR2A protein was performed on 5 µm thick formali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a3ccfb78496291f6e62e1bdd120eb2a
https://doi.org/10.1158/1078-0432.22479986.v1
https://doi.org/10.1158/1078-0432.22479986.v1
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Purpose:Aggressive meningiomas that progress after surgery/radiotherapy represent an unmet medical need. Strong and constant expression of SSTR2A receptors and activation of the Pi3K/Akt/mTOR pathway have been demonstrated in meningiomas. The combina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20fa21314544b2efd0bddb476e62749b
https://doi.org/10.1158/1078-0432.c.6530345
https://doi.org/10.1158/1078-0432.c.6530345
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Meningioma genes analyses The coding exons and exon-intron boundaries of 13 genes (NF2, AKT1, SMO, KLF4, TRAF7, PIK3CA, SUFU, SMARCB1, SMARCE1, CDKN2A, CDKN2B, PTEN and TERT was sequenced using the Custom QIAseq targeted DNA Panel (Qiagen, Germany) f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226af4d79bb9ca0df0553d00a0363632
https://doi.org/10.1158/1078-0432.22479974
https://doi.org/10.1158/1078-0432.22479974
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Genes tested in molecular analysis and references
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a73d783a751c91d7c141e2a787d348
https://doi.org/10.1158/1078-0432.22479980.v1
https://doi.org/10.1158/1078-0432.22479980.v1
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Study flow chart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8a14a0b49a56c7e037c605f3df61933
https://doi.org/10.1158/1078-0432.22479995.v1
https://doi.org/10.1158/1078-0432.22479995.v1
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Surface (2D area) growth rate before inclusion expressed in %/3months. Patients with a very high growth rate related to an initial very small tumor were not included in the pretreatement growth rate analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aba9e78b83895b1a091a96d115ee366
https://doi.org/10.1158/1078-0432.22479992
https://doi.org/10.1158/1078-0432.22479992
Autor:
Olivier Louis Chinot, Henry Dufour, Anne Barlier, Dominique Figarella-Branger, Karine Baumstarck, Mohamed Boucekine, Stéphane Honoré, Anita Cohen, Maryline Barrie, Emeline Tabouret, Stéphane Fuentes, Pierre-Hugues Roche, Michel Kalamarides, Catherine Roche, Didier Autran, Noémie Basset, Hadrien Peyrière, Matthieu Peyre, Ahmed Idbaih, Chantal Campello, Marc Sanson, Thomas Graillon
Volume curves for all patients integrating pre and under treatment 3D volume data by central review. *patients with drugs intake < 2 months ** pre/post operative MRI non-available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6ea9225dce91c94fc9191abd490891
https://doi.org/10.1158/1078-0432.22479989
https://doi.org/10.1158/1078-0432.22479989
Publikováno v:
Neuro-Oncology. 5:128-138
Although many patients with oligodendrogliomas (ODs) and oligoastrocytomas (OAs) benefit from a combination of surgery and adjuvant radiotherapy, most patients eventually experience recurrence of their disease. Recent evidence has shown that ODs are